References
- Kemp J P, Skoner D P, Szefler S J, Walton‐Bowen K, Cruz‐Rivera M, Smith J A. Once‐daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children. Ann Allergy, Asthma, & Immun 1999; 83: 231–239, [CSA]
- Mahajan P, Pearlman D, Okamoto L. The effect of fluticasone propionate on functional status and sleep in children with asthma and on the quality of life of their parents. J Allergy Clin Immunol 1998; 102: 19–23, [PUBMED], [INFOTRIEVE], [CSA]
- Szefler S J. Altering the course of asthma: introduction. J Allergy Clin Immunol 2002; 109: S519–S520, Supplement[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lemanske R F. Issues in understanding pediatric asthma: epidemiology and genetics. J Allergy Clin Immunol 2002; 109: S521–S524, Supplement[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kajosaari M, Syvanen P, Forars M, Juntunen‐Backman K. Inhaled corticosteroids during and after respiratory syncytial virus‐bronchiolitis may decrease subsequent asthma. Pediatr Allergy Immunol 2000; 11: 198–202, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Szefler S J. The natural history of asthma and early intervention. J Allergy Clin Immunol 2002; 109: S549–S553, Supplement[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma—Update on Selected Topics 2002. Publication 02‐5075. National Institutes of Health: Bethesda, MD, 2002
- Li J TC, Ford L B, Chervinsky P, Weisberg S C, Kellerman D J, Faulkner K G, Herje N E, Hamedani A, Harding S M, Shah T. Fluticasone propionate powder and lack of clinically significant effects on hypothalamic‐pituitary‐adrenal axis and bone mineral density over 2 years in adults with mild asthma. J Allergy Clin Immunol 1999; 103: 1062–1068, [PUBMED], [INFOTRIEVE], [CSA]
- Baraniuk J, Murray J J, Nathan R A, Berger W E, Johnson M, Edwards L D, Srebro S, Rickard K A. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma. Chest 1999; 116: 625–632, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ferguson A C, Spier S, Manjra A, Versteegh F GA, Mark S, Zhang P. Efficacy and safety of high‐dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide. J Pediatr 1999; 134: 422–427, [PUBMED], [INFOTRIEVE]
- Lipworth B J. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta‐analysis. Arch Intern Med 1999; 159: 941–955, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kavuru M, Melamed J, Gross G, LaForce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a ramdomized, double‐blind, placebo‐controlled trial. J Allergy Clin Immunol 2000; 105: 1108–1116, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Simons F ER. Benefits and risks of inhaled glucocorticoids in children with persistent asthma. J Allergy Clin Immunol 1998; 102: S77–S83, Supplement[PUBMED], [INFOTRIEVE], [CSA]
- Balfour‐Lynn L. Growth and childhood asthma. Arch Dis Child 1986; 61: 1049–1055
- Agertoft L, Pedersen S. Effect of long‐term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000; 343: 1064–1069, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- The Childhood Asthma Management Program Research Group. Long‐term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343: 1054–1063, [CROSSREF], [CSA]